The most common side effects reported with this drug were fatigue and headache.
When this drug was studied with ribavirin, the most common side effects were fatigue, anemia, nausea, headache, insomnia, and diarrhea.
The manufacturer product information for ribavirin should be consulted, if applicable.
Very common ( or more): Fatigue (up to )Common ( to ): Asthenia, irritability
Very common ( or more): Anemia , decreased hemoglobin (up to )
Decreases in hemoglobin to less than  g/dL and  g/dL during combination therapy were reported in  and  of subjects, respectively.
Very common ( or more): Headache (up to )
Very common ( or more): Nausea (up to )Common ( to ): Diarrhea, increased lipase
Isolated, asymptomatic lipase elevations (greater than  times the upper limit of normal [ x ULN]) were reported in up to  of subjects.
Very common ( or more): Insomnia (up to )Uncommon ( to ): Depressed mood
Serious symptomatic bradycardia has been reported in patients taking amiodarone who started therapy with sofosbuvir in combination with another hepatitis C virus (HCV) direct-acting antiviral.
Postmarketing reports: Serious symptomatic bradycardia (including fatal cardiac arrest, cases requiring pacemaker intervention)
Common ( to ): Rash
Common ( to ): Increased creatine kinase
Isolated, asymptomatic creatine kinase elevations (at least  x ULN) were reported in up to  of subjects.
Frequency not reported: Increased indirect bilirubin
Increased indirect bilirubin (up to  mg/dL above baseline) was reported in HIV-/HCV-coinfected patients using this drug and an atazanavir/ritonavir-based antiretroviral regimen.
Chest pain or discomfort
lightheadedness, dizziness or fainting
shortness of breath
slow or irregular heartbeat
unconsciousness
unusual tiredness
Fatigue
headache
Diarrhea
discouragement
feeling sad or empty
irritability
lack of appetite, nausea
lack or loss of strength
loss of interest or pleasure
rash
tiredness
trouble concentrating
trouble sleeping